Theravance Bio: 4Q Earnings Snapshot
GEORGE TOWN, Cayman Islands (AP) _ Theravance Biopharma Inc. (TBPH) on Tuesday reported a loss of $58.4 million in its fourth quarter.
On a per-share basis, the George Town, Cayman Islands-based company said it had a loss of 92 cents.
The results topped Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1.03 per share.
The biopharmaceutical company posted revenue of $18.7 million in the period, missing Street forecasts. Five analysts surveyed by Zacks expected $18.9 million.
For the year, the company reported that its loss widened to $278 million, or $4.46 per share. Revenue was reported as $71.9 million.
Theravance Bio shares have decreased roughly 1% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $17.65, a drop of 25% in the last 12 months.